Medical Care
Global Hospital Infection Therapeutics Market Research Report 2024
- Jan 26, 24
- ID: 28844
- Pages: 85
- Figures: 163
- Views: 30
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
The global Hospital Infection Therapeutics market was valued at US$ 2724.5 million in 2023 and is anticipated to reach US$ 3240.4 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Infection Therapeutics.
Report Scope
The Hospital Infection Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Infection Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Infection Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Segment by Type
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Segment by Application
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Infection Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Hospital Infection Therapeutics market was valued at US$ 2724.5 million in 2023 and is anticipated to reach US$ 3240.4 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Infection Therapeutics.
Report Scope
The Hospital Infection Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Infection Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Infection Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Segment by Type
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Segment by Application
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Infection Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Infection Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterial Drugs
1.2.3 Antiviral Drugs
1.2.4 Antifungal Drugs
1.3 Market by Application
1.3.1 Global Hospital Infection Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Acquired Pneumonia
1.3.3 Surgical Site Infections
1.3.4 Urinary Tract Infection
1.3.5 Gastrointestinal Disorders
1.3.6 Bloodstream Infections
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Infection Therapeutics Market Perspective (2019-2030)
2.2 Hospital Infection Therapeutics Growth Trends by Region
2.2.1 Global Hospital Infection Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital Infection Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Hospital Infection Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Hospital Infection Therapeutics Market Dynamics
2.3.1 Hospital Infection Therapeutics Industry Trends
2.3.2 Hospital Infection Therapeutics Market Drivers
2.3.3 Hospital Infection Therapeutics Market Challenges
2.3.4 Hospital Infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Infection Therapeutics Players by Revenue
3.1.1 Global Top Hospital Infection Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Hospital Infection Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Hospital Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Infection Therapeutics Revenue
3.4 Global Hospital Infection Therapeutics Market Concentration Ratio
3.4.1 Global Hospital Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Infection Therapeutics Revenue in 2023
3.5 Hospital Infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Hospital Infection Therapeutics Product Solution and Service
3.7 Date of Enter into Hospital Infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Infection Therapeutics Breakdown Data by Type
4.1 Global Hospital Infection Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Hospital Infection Therapeutics Forecasted Market Size by Type (2025-2030)
5 Hospital Infection Therapeutics Breakdown Data by Application
5.1 Global Hospital Infection Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Hospital Infection Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital Infection Therapeutics Market Size (2019-2030)
6.2 North America Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital Infection Therapeutics Market Size by Country (2019-2024)
6.4 North America Hospital Infection Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital Infection Therapeutics Market Size (2019-2030)
7.2 Europe Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital Infection Therapeutics Market Size by Country (2019-2024)
7.4 Europe Hospital Infection Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Infection Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Hospital Infection Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital Infection Therapeutics Market Size (2019-2030)
9.2 Latin America Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital Infection Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Hospital Infection Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Infection Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Hospital Infection Therapeutics Introduction
11.1.4 Bayer Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Johnson & Johnson Services
11.2.1 Johnson & Johnson Services Company Detail
11.2.2 Johnson & Johnson Services Business Overview
11.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Introduction
11.2.4 Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.2.5 Johnson & Johnson Services Recent Development
11.3 Actavis
11.3.1 Actavis Company Detail
11.3.2 Actavis Business Overview
11.3.3 Actavis Hospital Infection Therapeutics Introduction
11.3.4 Actavis Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.3.5 Actavis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Hospital Infection Therapeutics Introduction
11.4.4 Sanofi Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Bristol Myers Squibb Company
11.5.1 Bristol Myers Squibb Company Company Detail
11.5.2 Bristol Myers Squibb Company Business Overview
11.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Introduction
11.5.4 Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.5.5 Bristol Myers Squibb Company Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Hospital Infection Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Hospital Infection Therapeutics Introduction
11.7.4 Pfizer Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Hospital Infection Therapeutics Introduction
11.8.4 Merck Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.8.5 Merck Recent Development
11.9 GlaxoSmithkline
11.9.1 GlaxoSmithkline Company Detail
11.9.2 GlaxoSmithkline Business Overview
11.9.3 GlaxoSmithkline Hospital Infection Therapeutics Introduction
11.9.4 GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.9.5 GlaxoSmithkline Recent Development
11.10 Cubist Pharmaceuticals
11.10.1 Cubist Pharmaceuticals Company Detail
11.10.2 Cubist Pharmaceuticals Business Overview
11.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Introduction
11.10.4 Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.10.5 Cubist Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Infection Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterial Drugs
1.2.3 Antiviral Drugs
1.2.4 Antifungal Drugs
1.3 Market by Application
1.3.1 Global Hospital Infection Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Acquired Pneumonia
1.3.3 Surgical Site Infections
1.3.4 Urinary Tract Infection
1.3.5 Gastrointestinal Disorders
1.3.6 Bloodstream Infections
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Infection Therapeutics Market Perspective (2019-2030)
2.2 Hospital Infection Therapeutics Growth Trends by Region
2.2.1 Global Hospital Infection Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital Infection Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Hospital Infection Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Hospital Infection Therapeutics Market Dynamics
2.3.1 Hospital Infection Therapeutics Industry Trends
2.3.2 Hospital Infection Therapeutics Market Drivers
2.3.3 Hospital Infection Therapeutics Market Challenges
2.3.4 Hospital Infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Infection Therapeutics Players by Revenue
3.1.1 Global Top Hospital Infection Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Hospital Infection Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Hospital Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Infection Therapeutics Revenue
3.4 Global Hospital Infection Therapeutics Market Concentration Ratio
3.4.1 Global Hospital Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Infection Therapeutics Revenue in 2023
3.5 Hospital Infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Hospital Infection Therapeutics Product Solution and Service
3.7 Date of Enter into Hospital Infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Infection Therapeutics Breakdown Data by Type
4.1 Global Hospital Infection Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Hospital Infection Therapeutics Forecasted Market Size by Type (2025-2030)
5 Hospital Infection Therapeutics Breakdown Data by Application
5.1 Global Hospital Infection Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Hospital Infection Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital Infection Therapeutics Market Size (2019-2030)
6.2 North America Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital Infection Therapeutics Market Size by Country (2019-2024)
6.4 North America Hospital Infection Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital Infection Therapeutics Market Size (2019-2030)
7.2 Europe Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital Infection Therapeutics Market Size by Country (2019-2024)
7.4 Europe Hospital Infection Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Infection Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Hospital Infection Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital Infection Therapeutics Market Size (2019-2030)
9.2 Latin America Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital Infection Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Hospital Infection Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Infection Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Hospital Infection Therapeutics Introduction
11.1.4 Bayer Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Johnson & Johnson Services
11.2.1 Johnson & Johnson Services Company Detail
11.2.2 Johnson & Johnson Services Business Overview
11.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Introduction
11.2.4 Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.2.5 Johnson & Johnson Services Recent Development
11.3 Actavis
11.3.1 Actavis Company Detail
11.3.2 Actavis Business Overview
11.3.3 Actavis Hospital Infection Therapeutics Introduction
11.3.4 Actavis Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.3.5 Actavis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Hospital Infection Therapeutics Introduction
11.4.4 Sanofi Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Bristol Myers Squibb Company
11.5.1 Bristol Myers Squibb Company Company Detail
11.5.2 Bristol Myers Squibb Company Business Overview
11.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Introduction
11.5.4 Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.5.5 Bristol Myers Squibb Company Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Hospital Infection Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Hospital Infection Therapeutics Introduction
11.7.4 Pfizer Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Hospital Infection Therapeutics Introduction
11.8.4 Merck Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.8.5 Merck Recent Development
11.9 GlaxoSmithkline
11.9.1 GlaxoSmithkline Company Detail
11.9.2 GlaxoSmithkline Business Overview
11.9.3 GlaxoSmithkline Hospital Infection Therapeutics Introduction
11.9.4 GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.9.5 GlaxoSmithkline Recent Development
11.10 Cubist Pharmaceuticals
11.10.1 Cubist Pharmaceuticals Company Detail
11.10.2 Cubist Pharmaceuticals Business Overview
11.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Introduction
11.10.4 Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.10.5 Cubist Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hospital Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibacterial Drugs
Table 3. Key Players of Antiviral Drugs
Table 4. Key Players of Antifungal Drugs
Table 5. Global Hospital Infection Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hospital Infection Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Hospital Infection Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Hospital Infection Therapeutics Market Share by Region (2019-2024)
Table 9. Global Hospital Infection Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Hospital Infection Therapeutics Market Share by Region (2025-2030)
Table 11. Hospital Infection Therapeutics Market Trends
Table 12. Hospital Infection Therapeutics Market Drivers
Table 13. Hospital Infection Therapeutics Market Challenges
Table 14. Hospital Infection Therapeutics Market Restraints
Table 15. Global Hospital Infection Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Hospital Infection Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Hospital Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Infection Therapeutics as of 2023)
Table 18. Ranking of Global Top Hospital Infection Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Hospital Infection Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hospital Infection Therapeutics Product Solution and Service
Table 22. Date of Enter into Hospital Infection Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hospital Infection Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Hospital Infection Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Hospital Infection Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Hospital Infection Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Hospital Infection Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Hospital Infection Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Hospital Infection Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Hospital Infection Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Hospital Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Hospital Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Hospital Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Hospital Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Hospital Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Hospital Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Hospital Infection Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Hospital Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Hospital Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Hospital Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Hospital Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer Company Detail
Table 48. Bayer Business Overview
Table 49. Bayer Hospital Infection Therapeutics Product
Table 50. Bayer Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Bayer Recent Development
Table 52. Johnson & Johnson Services Company Detail
Table 53. Johnson & Johnson Services Business Overview
Table 54. Johnson & Johnson Services Hospital Infection Therapeutics Product
Table 55. Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Johnson & Johnson Services Recent Development
Table 57. Actavis Company Detail
Table 58. Actavis Business Overview
Table 59. Actavis Hospital Infection Therapeutics Product
Table 60. Actavis Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Actavis Recent Development
Table 62. Sanofi Company Detail
Table 63. Sanofi Business Overview
Table 64. Sanofi Hospital Infection Therapeutics Product
Table 65. Sanofi Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Bristol Myers Squibb Company Company Detail
Table 68. Bristol Myers Squibb Company Business Overview
Table 69. Bristol Myers Squibb Company Hospital Infection Therapeutics Product
Table 70. Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Bristol Myers Squibb Company Recent Development
Table 72. AstraZeneca Company Detail
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Hospital Infection Therapeutics Product
Table 75. AstraZeneca Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Pfizer Company Detail
Table 78. Pfizer Business Overview
Table 79. Pfizer Hospital Infection Therapeutics Product
Table 80. Pfizer Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Merck Company Detail
Table 83. Merck Business Overview
Table 84. Merck Hospital Infection Therapeutics Product
Table 85. Merck Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Merck Recent Development
Table 87. GlaxoSmithkline Company Detail
Table 88. GlaxoSmithkline Business Overview
Table 89. GlaxoSmithkline Hospital Infection Therapeutics Product
Table 90. GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 91. GlaxoSmithkline Recent Development
Table 92. Cubist Pharmaceuticals Company Detail
Table 93. Cubist Pharmaceuticals Business Overview
Table 94. Cubist Pharmaceuticals Hospital Infection Therapeutics Product
Table 95. Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 96. Cubist Pharmaceuticals Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Infection Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hospital Infection Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Antibacterial Drugs Features
Figure 4. Antiviral Drugs Features
Figure 5. Antifungal Drugs Features
Figure 6. Global Hospital Infection Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hospital Infection Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Hospital Acquired Pneumonia Case Studies
Figure 9. Surgical Site Infections Case Studies
Figure 10. Urinary Tract Infection Case Studies
Figure 11. Gastrointestinal Disorders Case Studies
Figure 12. Bloodstream Infections Case Studies
Figure 13. Others Case Studies
Figure 14. Hospital Infection Therapeutics Report Years Considered
Figure 15. Global Hospital Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Hospital Infection Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Hospital Infection Therapeutics Market Share by Region: 2023 VS 2030
Figure 18. Global Hospital Infection Therapeutics Market Share by Players in 2023
Figure 19. Global Top Hospital Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Infection Therapeutics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Hospital Infection Therapeutics Revenue in 2023
Figure 21. North America Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Hospital Infection Therapeutics Market Share by Country (2019-2030)
Figure 23. United States Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Hospital Infection Therapeutics Market Share by Country (2019-2030)
Figure 27. Germany Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Hospital Infection Therapeutics Market Share by Region (2019-2030)
Figure 35. China Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Hospital Infection Therapeutics Market Share by Country (2019-2030)
Figure 43. Mexico Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Hospital Infection Therapeutics Market Share by Country (2019-2030)
Figure 47. Turkey Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Bayer Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 50. Johnson & Johnson Services Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 51. Actavis Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 52. Sanofi Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 53. Bristol Myers Squibb Company Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 57. GlaxoSmithkline Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 58. Cubist Pharmaceuticals Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Hospital Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibacterial Drugs
Table 3. Key Players of Antiviral Drugs
Table 4. Key Players of Antifungal Drugs
Table 5. Global Hospital Infection Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hospital Infection Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Hospital Infection Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Hospital Infection Therapeutics Market Share by Region (2019-2024)
Table 9. Global Hospital Infection Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Hospital Infection Therapeutics Market Share by Region (2025-2030)
Table 11. Hospital Infection Therapeutics Market Trends
Table 12. Hospital Infection Therapeutics Market Drivers
Table 13. Hospital Infection Therapeutics Market Challenges
Table 14. Hospital Infection Therapeutics Market Restraints
Table 15. Global Hospital Infection Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Hospital Infection Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Hospital Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Infection Therapeutics as of 2023)
Table 18. Ranking of Global Top Hospital Infection Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Hospital Infection Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hospital Infection Therapeutics Product Solution and Service
Table 22. Date of Enter into Hospital Infection Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hospital Infection Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Hospital Infection Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Hospital Infection Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Hospital Infection Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Hospital Infection Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Hospital Infection Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Hospital Infection Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Hospital Infection Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Hospital Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Hospital Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Hospital Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Hospital Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Hospital Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Hospital Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Hospital Infection Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Hospital Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Hospital Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Hospital Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Hospital Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer Company Detail
Table 48. Bayer Business Overview
Table 49. Bayer Hospital Infection Therapeutics Product
Table 50. Bayer Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Bayer Recent Development
Table 52. Johnson & Johnson Services Company Detail
Table 53. Johnson & Johnson Services Business Overview
Table 54. Johnson & Johnson Services Hospital Infection Therapeutics Product
Table 55. Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Johnson & Johnson Services Recent Development
Table 57. Actavis Company Detail
Table 58. Actavis Business Overview
Table 59. Actavis Hospital Infection Therapeutics Product
Table 60. Actavis Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Actavis Recent Development
Table 62. Sanofi Company Detail
Table 63. Sanofi Business Overview
Table 64. Sanofi Hospital Infection Therapeutics Product
Table 65. Sanofi Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Bristol Myers Squibb Company Company Detail
Table 68. Bristol Myers Squibb Company Business Overview
Table 69. Bristol Myers Squibb Company Hospital Infection Therapeutics Product
Table 70. Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Bristol Myers Squibb Company Recent Development
Table 72. AstraZeneca Company Detail
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Hospital Infection Therapeutics Product
Table 75. AstraZeneca Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Pfizer Company Detail
Table 78. Pfizer Business Overview
Table 79. Pfizer Hospital Infection Therapeutics Product
Table 80. Pfizer Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Merck Company Detail
Table 83. Merck Business Overview
Table 84. Merck Hospital Infection Therapeutics Product
Table 85. Merck Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Merck Recent Development
Table 87. GlaxoSmithkline Company Detail
Table 88. GlaxoSmithkline Business Overview
Table 89. GlaxoSmithkline Hospital Infection Therapeutics Product
Table 90. GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 91. GlaxoSmithkline Recent Development
Table 92. Cubist Pharmaceuticals Company Detail
Table 93. Cubist Pharmaceuticals Business Overview
Table 94. Cubist Pharmaceuticals Hospital Infection Therapeutics Product
Table 95. Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 96. Cubist Pharmaceuticals Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Infection Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hospital Infection Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Antibacterial Drugs Features
Figure 4. Antiviral Drugs Features
Figure 5. Antifungal Drugs Features
Figure 6. Global Hospital Infection Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hospital Infection Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Hospital Acquired Pneumonia Case Studies
Figure 9. Surgical Site Infections Case Studies
Figure 10. Urinary Tract Infection Case Studies
Figure 11. Gastrointestinal Disorders Case Studies
Figure 12. Bloodstream Infections Case Studies
Figure 13. Others Case Studies
Figure 14. Hospital Infection Therapeutics Report Years Considered
Figure 15. Global Hospital Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Hospital Infection Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Hospital Infection Therapeutics Market Share by Region: 2023 VS 2030
Figure 18. Global Hospital Infection Therapeutics Market Share by Players in 2023
Figure 19. Global Top Hospital Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Infection Therapeutics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Hospital Infection Therapeutics Revenue in 2023
Figure 21. North America Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Hospital Infection Therapeutics Market Share by Country (2019-2030)
Figure 23. United States Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Hospital Infection Therapeutics Market Share by Country (2019-2030)
Figure 27. Germany Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Hospital Infection Therapeutics Market Share by Region (2019-2030)
Figure 35. China Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Hospital Infection Therapeutics Market Share by Country (2019-2030)
Figure 43. Mexico Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Hospital Infection Therapeutics Market Share by Country (2019-2030)
Figure 47. Turkey Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Hospital Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Bayer Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 50. Johnson & Johnson Services Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 51. Actavis Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 52. Sanofi Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 53. Bristol Myers Squibb Company Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 57. GlaxoSmithkline Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 58. Cubist Pharmaceuticals Revenue Growth Rate in Hospital Infection Therapeutics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232